View in EDS HTML Full Text PDF Full Text

Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.

Saved in:
Bibliographic Details
Title: Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
Authors: Yang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., He Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., Fan Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China. zhqfan@bjmu.edu.cn., Chen X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., Liu Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., Zhang C; Beijing Chao Yang Hospital, Breast Disease Department, Beijing, China., Jiang H; Beijing Chao Yang Hospital, Breast Disease Department, Beijing, China., Wang X; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China., Wang X; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China., Xie F; Peking University People's Hospital, Breast Cancer Center, Beijing, China., Wang S; Peking University People's Hospital, Breast Cancer Center, Beijing, China., Luo B; Beijing Tsinghua Changgeng Hospital, Breast Disease Department, Beijing, China., Kang H; Xuan Wu Hospital Capital Medical University, Breast Disease Department, Beijing, China., Wang T; 307 Hospital of PLA, Breast Cancer Department, Beijing, China., Jiang Z; 307 Hospital of PLA, Breast Cancer Department, Beijing, China., Yuan P; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China., Xu B; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China., Xu L; Peking University First Hospital, Breast Cancer Center, Beijing, China., Liu Y; Peking University First Hospital, Breast Cancer Center, Beijing, China., Li J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., Xie Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., Wang T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., Ouyang T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.
Source: NPJ breast cancer [NPJ Breast Cancer] 2023 Jul 24; Vol. 9 (1), pp. 62. Date of Electronic Publication: 2023 Jul 24.
Publication Type: Published Erratum
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37488099
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Fan+Z%22">Fan Z</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China. zhqfan@bjmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Beijing Chao Yang Hospital, Breast Disease Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Jiang+H%22">Jiang H</searchLink>; Beijing Chao Yang Hospital, Breast Disease Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Xie+F%22">Xie F</searchLink>; Peking University People's Hospital, Breast Cancer Center, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Peking University People's Hospital, Breast Cancer Center, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Luo+B%22">Luo B</searchLink>; Beijing Tsinghua Changgeng Hospital, Breast Disease Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Kang+H%22">Kang H</searchLink>; Xuan Wu Hospital Capital Medical University, Breast Disease Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+T%22">Wang T</searchLink>; 307 Hospital of PLA, Breast Cancer Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Z%22">Jiang Z</searchLink>; 307 Hospital of PLA, Breast Cancer Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Yuan+P%22">Yuan P</searchLink>; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Xu+B%22">Xu B</searchLink>; Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Xu+L%22">Xu L</searchLink>; Peking University First Hospital, Breast Cancer Center, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Peking University First Hospital, Breast Cancer Center, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Xie+Y%22">Xie Y</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+T%22">Wang T</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Ouyang+T%22">Ouyang T</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2023 Jul 24; Vol. 9 (1), pp. 62. <i>Date of Electronic Publication: </i>2023 Jul 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37488099
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-023-00567-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 62
    Titles:
      – TitleFull: Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: He Y
      – PersonEntity:
          Name:
            NameFull: Fan Z
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Zhang C
      – PersonEntity:
          Name:
            NameFull: Jiang H
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Xie F
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Luo B
      – PersonEntity:
          Name:
            NameFull: Kang H
      – PersonEntity:
          Name:
            NameFull: Wang T
      – PersonEntity:
          Name:
            NameFull: Jiang Z
      – PersonEntity:
          Name:
            NameFull: Yuan P
      – PersonEntity:
          Name:
            NameFull: Xu B
      – PersonEntity:
          Name:
            NameFull: Xu L
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Xie Y
      – PersonEntity:
          Name:
            NameFull: Wang T
      – PersonEntity:
          Name:
            NameFull: Ouyang T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 07
              Text: 2023 Jul 24
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1